Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence

American Journal on Addictions

Volumn 20, Issue 4, 2011, Pages 319-329

  Hobbs, Jennifer D J ^a   Kushner, Matt G ^a   Lee, Susanne S ^a   Reardon, Sean M ^b   Maurer, Eric W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Argosy University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPLE REUPTAKE INHIBITOR;

AGORAPHOBIA; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DEPRESSION; GENERALIZED ANXIETY DISORDER; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PANIC; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PHOBIA;

ADULT; ALCOHOLISM; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79959376250     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00140.x     Document Type: Article

References (75)

1. Grant BF, Harford TC,. Comorbidity between DSM-IV alcohol use disorders and major depression: Results of a national survey. Drug Alcohol Depend. 1995; 39: 197-206.
2. Kessler RC, McGonagle KA, Zhao S, et al,. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51: 8-19. (Pubitemid 24028993)
3. Kessler RC, Crum RM, Warner LA, et al,. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997; 53: 232-240.
4. Kushner MG, Krueger R, Frye B, et al,. Epidemiological perspectives on co-occurring anxiety disorder and substances use disorder. In:, Stewart SH, Conrod PJ, eds. Anxiety and Substances Use Disorders. Minnesota: Springer Science; 2007: 3-18.
5. Regier DA, Farmer ME, Rae DS, et al,. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264: 2511-2518.
6. Kushner MG, Abrams K, Thuras P, et al,. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res. 2005; 29: 1432-1443. (Pubitemid 41243368)
7. Ross HE, Glasser FB, Germanson T,. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988; 45: 1023-1031. (Pubitemid 18261765)
8. Gilman SE, Abraham HD,. A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend. 2001; 63: 277-286. (Pubitemid 32545414)
9. Grant BF, Stinson FS, Dawson DA, et al,. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Arch Gen Psychiatry. 2004; 61: 807-816. (Pubitemid 39031120)
10. Kranzler HR, Del Boca FK, Rounsaville BJ,. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: A post-treatment natural history study. J Stud Alcohol Drugs. 1996; 57: 619-626. (Pubitemid 26365617)
11. Ouimette PC, Ahrens C, Moos RH, et al,. Posttraumatic stress disorder in substance abuse patients: Relationship to 1-year posttreatment outcomes. Psychol Addict Behav. 1997; 11: 34-47. (Pubitemid 27167925)
12. Petrakis IL, Gonzalez G, Rosenheck R, et al,. Comorbidity of alcoholism and psychiatric disorders: An overview. Alcohol Res Health. 2002; 26: 81-89.
13. Salloum IM, Thase ME,. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000; 2: 269-280.
14. Tomasson K, Vaglum P,. The role of psychiatric comorbidity in the prediction of readmission for detoxification. Compr Psychiatry. 1998; 39: 129-136. (Pubitemid 28223920)
15. Driessen M, Meier S, Hill A, et al,. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol. 2001; 36: 249-255. (Pubitemid 32519861)
16. Book S, Randall C,. Social anxiety disorder and alcohol use. Alcohol Res Health. 2002; 26: 130-135.
17. Kushner MG, Donahue C, Sletten S, et al,. Cognitive behavioral treatment of comorbid anxiety disorder in alcoholism treatment patients: Presentation of a prototype program and future directions. J Ment Health. 2006; 15: 697-707. (Pubitemid 44808038)
18. Modesto-Lowe V, Kranzler HR,. Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders. Alcohol Res Health. 1999; 23: 144-149.
19. Ostacher M,. Comorbid alcohol and substance abuse dependence in depression: Impact on the outcome of antidepressant treatment. Psychiatr Clin North Am. 2007; 30: 69-76. (Pubitemid 46386306)
20. Ouimette PC, Brown PJ, Najavits LM,. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav. 1998; 23: 785-795. (Pubitemid 28443192)
21. Pettinati H,. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry. 2004; 56: 785-792. (Pubitemid 39539837)
22. Randall CL, Johnson MR, Thevos AK, et al,. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001; 14: 255-262. (Pubitemid 34013800)
23. Schade A, Marquenie LA, Van Balkom AJ, et al,. Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse Alcohol Alcohol. 2003; 38: 255-262. (Pubitemid 36582573)
24. Watkins KE, Hunter SB, Burnam MA, et al,. Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatr Serv. 2005; 56: 913-926. (Pubitemid 41098729)
25. Schade A, Marquenie LA, Van Balkom AJ, et al,. The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: A randomized controlled trial. Alcohol Clin Exp Res. 2005; 29: 794-800. (Pubitemid 40686550)
26. Cohen J,. Statistical Power Analysis for the Behavioral Sciences, Rev. ed. New York: Academic Press; 1977.
27. Rosenthal R, DiMatteo MR,. Meta-analysis: Recent developments in quantitative methods for literature review. Annu Rev Psychol. 2001; 52: 59-82. (Pubitemid 33705567)
28. Tiet QQ, Mausbach B,. Treatment for patients with dual diagnosis: A review. Alcohol Clin Exp Res. 2007; 31: 513-536. (Pubitemid 46434889)
29. Nunes EV, Levin FR,. Treatment of depression in patients with alcohol or drug dependence: A meta-analysis. JAMA. 2004; 291: 1887-1896. (Pubitemid 38509503)
30. Kendler KS, Prescott CA, Myers J, et al,. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003; 60: 929-937. (Pubitemid 37122313)
31. Krueger RF,. The structure of common mental disorders. Arch Gen Psychiatry. 1999; 56: 921-926. (Pubitemid 29480128)
32. Krueger RF, Finger MS,. Using item response theory to understand comorbidity among anxiety and unipolar mood disorders. Psychol Assess. 2001; 13: 140-151. (Pubitemid 32233821)
33. McGlinchey JB, Zimmerman M,. Examining a dimensional representation of depression and anxiety disorders' comorbidity in psychiatric outpatients with item response modeling. J Abnorm Psychol. 2007; 116: 464-474. (Pubitemid 47444682)
34. Mineka S, Watson D, Clark LA,. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol. 1998; 49: 377-412. (Pubitemid 128491779)
35. Schuckit MA,. Alcoholism and other psychiatric disorders. Hosp Community Psychiatry. 1983; 34: 1022-1027. (Pubitemid 14243333)
36. Moak DH, Anton RF, Latham PK, et al,. Sertraline and cognitive behavioral therapy for depressed alcoholics: Results of a placebo-controlled trial. J Clin Psychopharmacol. 2003; 23: 553-562. (Pubitemid 37443186)
37. McGrath PJ, Nunes EV, Stewart JW, et al,. Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Arch Gen Psychiatry. 1996; 53: 232-240.
38. Brown RA, Evans DM, Miller IW, et al,. Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol. 1997; 65: 715-726. (Pubitemid 27439063)
39. Bowen RC, D'arcy C, Keegan D, et al,. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav. 2000; 25: 593-597. (Pubitemid 30326755)
40. Kranzler HR, Mueller T, Cornelius J, et al,. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2006; 26: 13-20. (Pubitemid 43167084)
41. Roy A,. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biol Psychiatry. 1998; 44: 633-637. (Pubitemid 28496692)
42. Tollefson GD, Montague-Clouse J, Tollefson SI,. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (Buspirone). J Clin Psychopharmacol. 1992; 12: 19-26.
43. Borenstein M, Hedges LV, Higgins JPT, et al,. Introduction to Meta-Analysis. Hoboken, NJ: Wiley; 2009.
44. Dutra L, Stathopoulou G, Basden SL, et al,. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008; 165: 179-187. (Pubitemid 351704516)
45. Hamilton M,. The assessment of anxiety states by rating. Br J Psychol. 1959; 32: 50-55.
46. Conner KM, Davidson JRT, Churchill LE, et al,. Psychometric properties of the Social Phobia Inventory (SPIN): A new self-rating scale. Br J Psychiatry. 2000; 176: 379-386.
47. Derogatis IR,. SCL-90. In: Administration, Scoring and Procedures Manual-I for the Revised Version. Maryland: John Hopkins University School of Medicine; 1977.
48. Watson JP, Marks IM,. Relevant and irrelevant fear in flooding: A crossover study of phobic patients. Behav Ther. 1971; 2: 275-293.
49. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56-62.
50. Beck AT, Ward CH, Mendelson M, et al,. An inventory for measuring depression. Arch Gen Psychiatry. 1961: 4; 561-571.
51. McNair DM, Lorr M, Droppleman LF,. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
52. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134: 382-389. (Pubitemid 9136500)
53. Borenstein M, Rothstein H,. Comprehensive meta-analysis software: Version 2.2. Englewood, NJ: Biostat Inc.; 1999.
54. Egger M, Smith GD,. Meta-analysis: Potentials and promise. BMJ. 1997; 315: 1371-1374.
55. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
56. Duval S, Tweedie R,. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56: 455-463. (Pubitemid 30422636)
57. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558. (Pubitemid 34746062)
58. Cornelius JR, Salloum IM, Ehler JG, et al,. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1997; 54: 700-705. (Pubitemid 27344096)
59. Gual A, Balcells M, Torres M, et al,. Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: A randomized controlled trial. Alcohol Alcohol. 2003; 38: 619-625. (Pubitemid 37455862)
60. Hernandez-Avila CA, Modesto-Lowe V, Feinn R, et al,. Nefazodone treatment of comorbid alcohol dependence and major depression. Alcohol Clin Exp Res. 2004; 28: 433-440. (Pubitemid 38380746)
61. Kranzler HR, Burleson JA, DelBoca FK, et al,. Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Arch Gen Psychiatry. 1994; 51: 720-731. (Pubitemid 24281783)
62. Malcolm R, Anton RF, Randall C, et al,. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res. 1992; 16: 1007-1013. (Pubitemid 23005139)
63. Roy-Byrne PP, Pages KP, Russo JE, et al,. Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2000; 20: 129-136. (Pubitemid 30202353)
64. Blanco C, Schneier FR, Schmidt A, et al,. Pharmacological treatment of social anxiety disorder: A meta analysis. Depress Anxiety. 2003; 18: 29-40. (Pubitemid 37012933)
65. Deacon BJ, Abramowitz JS,. Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. J Clin Psychol. 2004; 60: 429-441. (Pubitemid 38375151)
66. Ekers D, Richards D, Gilbody SM,. A meta-analysis of randomized trials of behavioural treatment of depression. Psychol Med. 2008; 38: 611-623. (Pubitemid 351483232)
67. Gould RA, Otto MW, Pollack MP, et al,. Cognitive-behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behav Ther. 1997; 28: 285-305. (Pubitemid 27422460)
68. Hofmann SG, Smits JAJ,. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008; 69: 621-632. (Pubitemid 351792338)
69. Joffe R, Sokolov S, Streiner D,. Antidepressant treatment of depression: A meta analysis. Can J Psychiatry. 1996; 41: 613-616. (Pubitemid 27062617)
70. Norton PJ, Price EP,. A meta-analytic review of cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis. 2007; 195: 521-531. (Pubitemid 46945492)
71. Beecher HK,. The powerful placebo. JAMA. 1955; 59: 1602-1606.
72. Khan A, Khan S, Brown WA,. Are placebo controls necessary to test new antidepressants and anxiolytics Int J Neuropsychopharmacol. 2002; 5: 192-197.
73. Khan A, Kolts RL, Rapaport MH, et al,. Magnitude of placebo response and drug-placebo differences across psychiatric disrorders. Psych Med. 2005; 35: 743-749. (Pubitemid 40716438)
74. Walsh BT, Seidman SN, Sysko R, et al,. Placebo response in studies of major depression. JAMA. 2002; 287: 1840-1847.
75. Kushner MG, Abrams K, Thuras P, et al,. Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder. Alcohol Clin Exp Res. 2000; 24: 448-458. (Pubitemid 30244242)